NCT01091103 2018-10-23
Determine Effect of Enzalutamide (MDV3100) on the Androgen Signaling Pathway in Correlation With the Anti-tumor Effects of Enzalutamide
Pfizer
Phase 2 Completed
Clinical Trials
1 trialsInterventional × Has results × Metastatic Progressive Castration-resistant Prostate Cancer × Clear all